University of Kentucky Markey Cancer Center researchers have discovered a promising new way to combat therapy-resistant ...

The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side ...

Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...

Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme—P4HA1 prolyl hydroxylase, ...

Vertex and the UK’s genome analysis firm Genomics plc have announced a three-year collaboration to use human genetics and machine learning to improve discovery of targets for precision drugs.

B-cell lymphoma, particularly diffuse large B-cell lymphoma (DLBCL), is a type of cancer that originates ... making it a promising target for therapeutic intervention. Recent studies have made ...

to identify new therapeutic targets. A clinical trial that added an immunotherapy drug to standard of care treatment regimens has shown increased survival rates for head and neck cancer patients with ...

"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...

Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme – P4HA1 prolyl hydroxylase ...

In this third-generation delivery strain, Raman figured out a way to control when the bacteria, after it has been intravenously injected, invades the cancer cells and delivers the therapy. This ...

A new review was published in Oncotarget's Volume 16 on January 20, 2025, titled "Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms." ...

Individualized treatments for cancer show great promise, and three KC-area providers are dialing up their offerings.